SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

09 May 2023 Evaluate
The March 2023 quarter revenue stood at Rs. 65.94 millions, up 24.60% as compared to Rs. 52.92 millions during the corresponding quarter last year.The Profit  for the quarter ended March 2023 of  Rs. 2.83  millions  grew by 91.22% from Rs. 1.48 millions.The company reported a good operating profit of 5.73 millions compared to 4.55 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 65.94 52.92 24.60 183.21 254.32 -27.96 183.21 254.32 -27.96
Other Income 2.08 2.05 1.46 8.55 6.53 30.93 8.55 6.53 30.93
PBIDT 5.73 4.55 25.93 18.10 19.68 -8.03 18.10 19.68 -8.03
Interest 0.35 1.06 -66.98 1.50 4.64 -67.67 1.50 4.64 -67.67
PBDT 5.38 3.49 54.15 16.60 15.04 10.37 16.60 15.04 10.37
Depreciation 1.60 1.56 2.56 6.33 5.62 12.63 6.33 5.62 12.63
PBT 3.78 1.93 95.85 10.27 9.42 9.02 10.27 9.42 9.02
TAX 0.95 0.45 111.11 2.57 2.36 8.90 2.57 2.36 8.90
Deferred Tax 0.47 0.45 4.44 2.09 2.34 -10.68 2.09 2.34 -10.68
PAT 2.83 1.48 91.22 7.70 7.06 9.07 7.70 7.06 9.07
Equity 83.16 83.16 0.00 83.16 83.16 0.00 83.16 83.16 0.00
PBIDTM(%) 8.69 8.60 1.07 9.88 7.74 27.67 9.88 7.74 27.67

Eiko Lifesciences Share Price

50.18 0.24 (0.48%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×